Efficacy and safety of rivaroxaban in prevention and therapy of thromboembolic events in patients with nonvalvular atrial fibrillation

Efficacy and safety of rivaroxaban in prevention and therapy of thromboembolic events in patients with nonvalvular atrial fibrillation

Context: Rivaroxaban is an oral direct factor Xa inhibitor reducing the risk of systemic embolism and stroke in patients with nonvalvular atrial fibrillation. Aims: The primary objective was to evaluate the effectiveness of rivaroxaban therapy in reducing the risk of systemic embolism and stroke in...

Full description

Bibliographic Details
Main Authors: Tamara Kovačević Preradovic, Siniša Miljković, Ljiljana Kos, Aziz Šukalo, Una Glamočlija, Amna Tanović Avdić, Meliha Mehić
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Journal of the Practice of Cardiovascular Sciences
Subjects:
nonvalvular atrial fibrillation
rivaroxaban
stroke
systemic embolism
Online Access:http://www.j-pcs.org/article.asp?issn=2395-5414;year=2023;volume=9;issue=2;spage=110;epage=115;aulast=Preradovic

Internet

http://www.j-pcs.org/article.asp?issn=2395-5414;year=2023;volume=9;issue=2;spage=110;epage=115;aulast=Preradovic

Similar Items